Regenosca
About:
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.
Website: https://www.regenosca.com/
Top Investors: Venture Kick, MassChallenge, Business Angels Switzerland (BAS), Foundation for Innovation and Technology (FIT)
Description:
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair. Regenosca brings regeneration over scarring with our medical devices.
Total Funding Amount:
1.29M CHF
Headquarters Location:
Lausanne, Vaud, Switzerland
Founded Date:
2019-01-10
Contact Email:
contact(AT)regenosca.com
Founders:
Eva-Maria Balet
Number of Employees:
1-10
Last Funding Date:
2024-07-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai